Richard A. Rudick
Annals of Neurology · 2000–2017
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Whom Richard A. Rudick trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Richard A. Rudick overall
Papers from Richard A. Rudick's perspective
Ordered by how strongly the researchers Richard A. Rudick trusts endorse each paper. Same corpus, a different order for every researcher.
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (Annals of Neurology)
- Identifying biological themes within lists of genes with EASE (Genome Biology)
- Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways (Nature Neuroscience)
- CNS energy metabolism as related to function. (Brain research. Brain research reviews)
- The Yin and Yang of NMDA receptor signalling. (Trends in Neurosciences)
- Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients (Annals of Neurology)
- On the Statistical Analysis of Dirty Pictures
- A THEOREM ABOUT RANDOM FIELDS
- Statistical Analysis of Non-Lattice Data
- Monte Carlo Sampling Methods Using Markov Chains and Their Applications
Their papers
- Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis (2017) — 795 citations
- Defining the clinical course of multiple sclerosis (2014) — 2,587 citations
- Gray matter atrophy in multiple sclerosis: A longitudinal study (2008) — 670 citations
- Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. (2006) — 1,340 citations
- Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients (2006) — 862 citations
- Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. (2002) — 958 citations
- Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients (2000) — 600 citations